EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 253 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,430 | -5.2% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $15,229 | +13.5% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $13,414 | +688.1% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,702 | -99.9% | 1,850 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $2,468,000 | -39.3% | 1,850 | -14.0% | 0.01% | -33.3% |
| Q2 2022 | $4,067,000 | -0.3% | 2,150 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $4,081,000 | -49.2% | 2,150 | 0.0% | 0.01% | -50.0% |
| Q4 2021 | $8,033,000 | -0.4% | 2,150 | 0.0% | 0.02% | -5.3% |
| Q3 2021 | $8,062,000 | -53.0% | 2,150 | -37.7% | 0.02% | -52.5% |
| Q2 2021 | $17,170,000 | +34.8% | 3,450 | -5.5% | 0.04% | +17.6% |
| Q1 2021 | $12,740,000 | -40.1% | 3,650 | -2.7% | 0.03% | -41.4% |
| Q4 2020 | $21,274,000 | +7.9% | 3,750 | +7.1% | 0.06% | +544.4% |
| Q3 2020 | $19,720,000 | -5.2% | 3,500 | -2.8% | 0.01% | -25.0% |
| Q2 2020 | $20,791,000 | -80.5% | 3,600 | -75.5% | 0.01% | -83.6% |
| Q1 2020 | $106,394,000 | – | 14,688 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |